New study 🚨
Identifying predictors of SGLT-2i and GLP1RA use in hospital 
🚨 Low use  (SGLT-2i 3.7%, GLP1 0.2%) 
🚨 47% of pts with T2D &amp; CVD, HF, or renal dx would benefit from SGLT-2i before discharge@FralickMike @DrFahadRazak @AmolAVerma @TorBiering